Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
04/07/1999 | EP0906283A1 Substituted benzamide derivatives and their use as anticonvulsants |
04/07/1999 | EP0906279A1 Novel pyrrole derivatives |
04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
04/07/1999 | EP0906100A1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
04/07/1999 | EP0906094A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
04/07/1999 | EP0796297B1 Methine dyes based one formylaminopyridones |
04/07/1999 | EP0683776B1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria |
04/07/1999 | EP0669824B1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
04/07/1999 | EP0607374B1 Novel cyclic lipid derivatives as potent paf antagonists |
04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
04/07/1999 | CN1213369A Quinoxalinediones |
04/07/1999 | CN1213366A New processes for preparing pesticidal intermediates |
04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
04/06/1999 | US5892112 Acylation of amino acids with anhydrides or carboxy groups, amidation with amine and conversion of acid or ester to hydroxamic acid and hydrolysis |
04/06/1999 | US5892056 The rigidified chromophores have narrowed absorption bands relative to corresponding non-rigid chromophores. dyes prepared from the dye precursors of the invention typically have good solubility in non-polar solvents. |
04/06/1999 | US5892052 Process for making retroviral protease inhibiting compounds |
04/06/1999 | US5892048 Triazole compounds and pest control agent |
04/06/1999 | US5892046 Methine and azamethine dyes based on trifluoromethylpyridones |
04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
04/06/1999 | US5892038 Hydroxy-amino acid amides |
04/06/1999 | US5892033 Metallic chelating dye |
04/06/1999 | US5892032 Amidation of heteroaromatic halogen compounds with aromatic amines and carbon monoxide using palladium phospine complex catalyst; herbicides |
04/06/1999 | US5891906 Antiinflammatory agents using benzoditerpenes and benzolactams |
04/06/1999 | US5891902 Osteoporosis |
04/06/1999 | US5891889 Inhibit farnesylation of oncogene protein ras |
04/06/1999 | US5891884 Use of an imidazole derivative for preventing and/or treating rhinitis |
04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
04/06/1999 | US5891877 Pharmaceutical compounds |
04/06/1999 | US5891876 Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (ampa); drugs that enhance these receptor currents will facilitate communication in brain networks responsible for perceptual-motor integration and higher order behaviors |
04/06/1999 | US5891872 Inhibit farnesyl-protein transferase |
04/06/1999 | US5891870 Antiinflammatory agents using benzoditerpenes and benzolactams |
04/06/1999 | CA2152794C Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
04/06/1999 | CA1340487C Ph-neutral aqueous solutions of quinolone-carboxylic acids |
04/01/1999 | WO1999015894A2 Method of identification of leads or active compounds |
04/01/1999 | WO1999015523A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
04/01/1999 | WO1999015506A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
04/01/1999 | WO1999015504A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
04/01/1999 | WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
04/01/1999 | WO1999015178A1 Vitronectin receptor antagonist |
04/01/1999 | WO1999015170A1 Vitronectin receptor antagonist |
04/01/1999 | WO1999014998A2 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
04/01/1999 | WO1999002497A3 Pyridine derivatives |
04/01/1999 | DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents |
04/01/1999 | CA2304849A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
04/01/1999 | CA2304783A1 Method of identification of leads or active compounds |
04/01/1999 | CA2304647A1 Method for preventing and treating hearing loss using sensorineurotophic compounds |
04/01/1999 | CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
04/01/1999 | CA2304000A1 Vitronectin receptor antagonist |
04/01/1999 | CA2303846A1 Vitronectin receptor antagonist |
04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
03/31/1999 | EP0905512A1 Method of identification of leads or active compounds |
03/31/1999 | EP0905134A1 Piperidine derivatives as LTD4 and H1 antagonists |
03/31/1999 | EP0905133A1 Tetrazole derivatives as LTD4 and H1 antagonists |
03/31/1999 | EP0905129A1 Substituted amidinobenzene derivatives and medicinal compositions thereof |
03/31/1999 | EP0904262A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
03/31/1999 | EP0904080A1 Inhibitors of farnesyl-protein transferase |
03/31/1999 | EP0904076A1 Inhibitors of farnesyl-protein transferase |
03/31/1999 | EP0637298B1 Substituted cyclohexene-1,2-bicarboxylic acid derivatives and raw materials for producing them |
03/31/1999 | CN1212705A Serine protease inhibitors |
03/31/1999 | CN1212692A Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use |
03/31/1999 | CN1212687A 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
03/31/1999 | CN1042690C Herbicidal composition containing substituted pyridinesulfonamide compounds |
03/30/1999 | US5889184 Process for pyrimidinone compounds |
03/30/1999 | US5889163 Method for producing azo dye compounds |
03/30/1999 | US5889161 Igniter for air bags; rocket propellant; detonators |
03/30/1999 | US5889035 1-(Arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics |
03/30/1999 | US5889026 N-methyl-d-asparatate-receptor subtype selective blocker |
03/30/1999 | US5889024 Substituted heterocycles |
03/30/1999 | US5889023 Fibrinogen receptor antagonist |
03/30/1999 | US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists |
03/30/1999 | US5889018 Heterocyclic compounds, pharmaceutical compositions comprising them and process for the preparation thereof |
03/30/1999 | US5889016 Blocking neuropeptide y |
03/30/1999 | US5889009 Method of inhibiting cell adhesion |
03/30/1999 | US5889007 Chemisensitizing agents; cancer therapy drug resistance |
03/30/1999 | US5889006 Muscarinic antagonists |
03/30/1999 | US5889005 Benzamidine derivatives and their use for treating thrombotic diseases |
03/30/1999 | US5889004 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their therapeutic utility |
03/30/1999 | US5888998 Increase effectiveness of b-lactam antibiotics |
03/30/1999 | US5888992 Polar substituted hydrocarbons |
03/30/1999 | US5888941 Carbozamides with antifungal activity |
03/30/1999 | US5888535 Antiulcer agents, reduced side effects |
03/30/1999 | CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use |
03/30/1999 | CA1340470C Quinoline, quinazoline, and cinnoline fungicides |
03/25/1999 | WO1999014215A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
03/25/1999 | WO1999014214A1 Antimicrobial quinolones, their compositions and uses |
03/25/1999 | WO1999014204A1 Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
03/25/1999 | WO1999014203A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
03/25/1999 | WO1999014197A1 Substituted isoquinolines as anticonvulsivants |
03/25/1999 | WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
03/25/1999 | WO1999013911A1 Nootropic agent |
03/25/1999 | WO1999001103A3 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
03/25/1999 | WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors |
03/25/1999 | DE19741399A1 New tetrahydroquinoline derivatives useful in treatment of elevated lipid levels and arteriosclerosis |
03/25/1999 | DE19741051A1 New tetrahydroquinoline derivatives useful in treatment of raised lipid levels and arteriosclerosis |
03/25/1999 | CA2303777A1 Substituted isoquinolines as anticonvulsivants |
03/25/1999 | CA2302453A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
03/25/1999 | CA2301782A1 Nootropic agent |